Skip to content
ppharmaranks
Menu

Best treatments for colorectal neoplasms

8 products may treat colorectal neoplasms, spanning FDA drug classes such as nucleoside metabolic inhibitor, alkylating drug, lymphocyte growth factor. The current highest-rated option is vectibix. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 8 drugs we list for colorectal neoplasms, 1 is available as lower-cost generics, spanning classes such as nucleoside metabolic inhibitor, alkylating drug, lymphocyte growth factor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for colorectal neoplasms — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate
Treatments we list for colorectal neoplasms
#DrugRatingPharmacy pays
172/100View →
2Not yet rated$14View →
3Not yet ratedView →
4Not yet ratedView →
5Not yet ratedView →
6Not yet ratedView →
7Not yet ratedView →
8Not yet ratedView →

Narrow by drug class

Explore the class hubs: alkylating drug

Full ranking · 8 treatments

Frequently asked

What treats colorectal neoplasms?
Our catalog lists 8 products that may treat colorectal neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is vectibix.
What is the best-rated treatment for colorectal neoplasms?
By our independent recall-safety rating — not an efficacy measure — vectibix ranks highest among the products we list for colorectal neoplasms. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat colorectal neoplasms?
Treatments for colorectal neoplasms span FDA drug classes including nucleoside metabolic inhibitor, alkylating drug, lymphocyte growth factor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.